228 related articles for article (PubMed ID: 26927614)
1. Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.
Aravind SR; Krishnan LK
Int Immunopharmacol; 2016 May; 34():78-85. PubMed ID: 26927614
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of curcumin from fibrin matrix induces cancer cell death and immunomodulation.
Aravind SR; Lakshmi S; S R; Krishnan LK
Biomed Pharmacother; 2021 Jan; 133():110967. PubMed ID: 33221650
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects.
Tang H; Murphy CJ; Zhang B; Shen Y; Sui M; Van Kirk EA; Feng X; Murdoch WJ
Nanomedicine (Lond); 2010 Aug; 5(6):855-65. PubMed ID: 20735222
[TBL] [Abstract][Full Text] [Related]
5. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
6. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
[TBL] [Abstract][Full Text] [Related]
7. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.
Babaei E; Sadeghizadeh M; Hassan ZM; Feizi MA; Najafi F; Hashemi SM
Int Immunopharmacol; 2012 Jan; 12(1):226-34. PubMed ID: 22155627
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.
Perry MC; Demeule M; Régina A; Moumdjian R; Béliveau R
Mol Nutr Food Res; 2010 Aug; 54(8):1192-201. PubMed ID: 20087857
[TBL] [Abstract][Full Text] [Related]
10. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
11. Potential anticancer activity of turmeric (Curcuma longa).
Kuttan R; Bhanumathy P; Nirmala K; George MC
Cancer Lett; 1985 Nov; 29(2):197-202. PubMed ID: 4075289
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin.
Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W
Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the methanolic extract of Ammannia baccifera L. against Dalton's ascites lymphoma induced ascitic and solid tumors in mice.
Loganayaki N; Manian S
J Ethnopharmacol; 2012 Jun; 142(1):305-9. PubMed ID: 22613234
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin enhances curcumin's cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptake.
Klippstein R; Bansal SS; Al-Jamal KT
Int J Pharm; 2016 Nov; 514(1):169-175. PubMed ID: 27863661
[TBL] [Abstract][Full Text] [Related]
16. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines.
Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S
Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828
[TBL] [Abstract][Full Text] [Related]
17. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.
Shankar S; Srivastava RK
Carcinogenesis; 2007 Jun; 28(6):1277-86. PubMed ID: 17277231
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
19. Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice.
Guorgui J; Wang R; Mattheolabakis G; Mackenzie GG
Arch Biochem Biophys; 2018 Jun; 648():12-19. PubMed ID: 29679536
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
